Drug Discovery Chemistry 2013

Drug Discovery Chemistry is the leading discovery event in medicinal chemistry. Focused on novel small molecules as therapeutic targets, with a strong emphasis on a chemistry-based approach, this unique event brings together top experts with backgrounds in medicinal chemistry, biochemistry and life sciences to discuss cutting-edge research in the important areas of:

Anti-Inflammatories
Kinase Inhibitor Chemistry
Fragment-Based Drug Discovery
Protein-Protein Interactions
Constrained Peptides & Macrocyclics Drug Discovery
GPCR-Based Drug Design

Speakers
Samarjit Patnaik, Ph.D., Research Scientist, National Center for Advancing Translational Sciences, NIH
Peter H. Schafer, Ph.D., Senior Principal Investigator, Translational Development, Celgene Corporation
C. Eric Schwartz, Ph.D., Senior Director, Chemistry, Celgene Avilomics Research
Nick Terrett, Ph.D., CSO, Ensemble Therapeutics Corp.
Suvit Thaisrivongs, Ph.D., Executive Director, Chemistry, Pfizer
and many more.